Suicheng Pharmaceutical Co., Ltd.
-
Founded in:
1997-10-17 -
Country:
China -
Address:
No. 219, Qing'an Road, Xinzheng City -
Tax NO.:
91410100712635557P -
Registered Funds:
111.68 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Galantamine Hydrobromide |
It is an acetylcholinesterase inhibitor. It can penetrate the blood-brain barrier and counteract non-depolarizing muscle relaxants. It also has a direct excitatory effect on the N2 cholinergic receptors on the motor plate, which can improve neuromuscular conduction. It also has a certain central cholinergic effect.
More
It is an acetylcholinesterase inhibitor. It can penetrate the blood-brain barrier and counteract non-depolarizing muscle relaxants. It also has a direct excitatory effect on the N2 cholinergic receptors on the motor plate, which can improve neuromuscular conduction. It also has a certain central cholinergic effect. |
1953-04-4 | 18 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fleeceflower root HRS |
|
0 | ||
| SOPHORAE FRUCTUS |
|
0 | ||
| Chrysanthemum |
|
0 | ||
| lycii Fructus |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pazufloxacin mesilate |
This product belongs to the quinolone antibacterial drug. Its main mechanism of action is to inhibit the activity of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus, hinder DNA synthesis and cause bacterial death; it has a weak inhibitory effect on human topoisomerase II. This product has the characteristics of a broad antibacterial spectrum and strong antibacterial effect. It has good antibacterial activity against G+ bacteria such as Staphylococcus, Streptococcus, Enterococcus, and against G- bacteria such as Escherichia coli, Proteus mirabilis, Klebsiella, Enterobacter cloacae, Citrobacter rodentium, Acinetobacter calcoaceticus, Haemophilus influenzae, Moraxella catarrhalis, Pseudomonas aeruginosa, etc. This product also has good antibacterial activity against some anaerobic bacteria such as Clostridium perfringens, Fusobacterium nucleatum, Propionibacterium acnes, Porphyromonas, some Peptostreptococci, Bacteroides fragilis and Prevotella.
More
This product belongs to the quinolone antibacterial drug. Its main mechanism of action is to inhibit the activity of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus, hinder DNA synthesis and cause bacterial death; it has a weak inhibitory effect on human topoisomerase II. This product has the characteristics of a broad antibacterial spectrum and strong antibacterial effect. It has good antibacterial activity against G+ bacteria such as Staphylococcus, Streptococcus, Enterococcus, and against G- bacteria such as Escherichia coli, Proteus mirabilis, Klebsiella, Enterobacter cloacae, Citrobacter rodentium, Acinetobacter calcoaceticus, Haemophilus influenzae, Moraxella catarrhalis, Pseudomonas aeruginosa, etc. This product also has good antibacterial activity against some anaerobic bacteria such as Clostridium perfringens, Fusobacterium nucleatum, Propionibacterium acnes, Porphyromonas, some Peptostreptococci, Bacteroides fragilis and Prevotella. |
163680-77-1 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acyclovir |
This product is a synthetic nucleoside antiviral drug, which has inhibitory effects on herpes simplex virus type I (HSV-1), type H (HSV-2) and varicella-zoster virus (VZV) in vivo and in vitro. Cell culture results show that this product has the strongest inhibitory effect on HSV-1 virus, followed by HSV-2 and VZV virus. Because this product has affinity for thymidine kinase (TK) encoded by HSV and VZV, it has a highly selective inhibitory effect. This type of viral enzyme converts acyclovir into acyclovir monophosphate, a nucleoside analog. The monophosphate is further converted into diphosphate by guanylate kinase in the cell, and then converted into triphosphate by multiple enzymes in the cell. In vitro, acyclovir triphosphate stops herpes virus DNA replication.
More
This product is a synthetic nucleoside antiviral drug, which has inhibitory effects on herpes simplex virus type I (HSV-1), type H (HSV-2) and varicella-zoster virus (VZV) in vivo and in vitro. Cell culture results show that this product has the strongest inhibitory effect on HSV-1 virus, followed by HSV-2 and VZV virus. Because this product has affinity for thymidine kinase (TK) encoded by HSV and VZV, it has a highly selective inhibitory effect. This type of viral enzyme converts acyclovir into acyclovir monophosphate, a nucleoside analog. The monophosphate is further converted into diphosphate by guanylate kinase in the cell, and then converted into triphosphate by multiple enzymes in the cell. In vitro, acyclovir triphosphate stops herpes virus DNA replication. |
59277-89-3 | 50 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dandelion extract |
Antibacterial, antiviral, anti-inflammatory
More
Antibacterial, antiviral, anti-inflammatory |
84775-55-3 | 0 | |
| DAURICINE |
Antibacterial, antiviral, anti-inflammatory
More
Antibacterial, antiviral, anti-inflammatory |
524-17-4 | 0 | |
| Baical Skullcap Root Extract |
Antibacterial, antiviral, anti-inflammatory, has antibacterial effect on many bacteria
More
Antibacterial, antiviral, anti-inflammatory, has antibacterial effect on many bacteria |
0 | ||
| BERBERINE CHLORIDE |
Antibacterial, antiviral, anti-inflammatory
More
Antibacterial, antiviral, anti-inflammatory |
141433-60-5 | 0 |